Xtant Medical

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$35,411
$32,904
$31,513
$27,937
Gross Profit
24,284
20,243
16,024
16,307
EBITDA
5,978
2,137
-862
-2,690
EBIT
4,809
1,063
-2,010
-3,763
Net Income
3,550
58
-3,165
-5,024
Net Change In Cash
35,411
32,904
31,513
27,937
Free Cash Flow
910
87
-7
-3,822
Cash
6,923
5,032
6,199
6,596
Basic Shares
148,574
143,335
138,977
135,100

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$117,267
$91,303
$57,969
$55,263
Gross Profit
68,216
55,467
32,137
32,490
EBITDA
-7,878
5,075
-5,428
-2,513
EBIT
-12,102
1,901
-6,724
-3,854
Net Income
-16,449
660
-8,485
-4,849
Net Change In Cash
117,267
91,303
57,969
55,263
Cost of Revenue
2,120
Free Cash Flow
-16,009
-10,971
-7,105
-1,676
Cash
6,199
5,715
20,298
18,243
Basic Shares
133,665
126,793
94,085
85,456

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
$0.02
2025-03-31
$0.27
2024-12-31
-$0.01